PCVX
HealthcareVaxcyte, Inc.
$54.52-1.69 (-3.01%)
Prev Close
$56.21
Open
$57.06
High
$57.90
Low
$53.24
Volume
949.3K
Market Cap
$8.42B
P/E
—
Div Yield
—
Over the past 12 months, insider activity at Vaxcyte, Inc. (PCVX) has been exclusively selling, with 0 insider purchases totaling $0.00 and 5 insider sales totaling $829.8K. The most recent insider transaction was by Cowan Elvia (officer: SVP, Finance & CAO), who sold $146.5K worth of shares on Mar 11, 2026. Vaxcyte, Inc. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $8.42B.
Buys (12M)
0
$0.00
Sells (12M)
5
$829.8K
Net Activity
Net Seller
$829.8K
Active Insiders
4
last 12 mo
PCVX Price Chart
PCVX Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Mar 11, 2026↗ | Cowan Elvia | officer: SVP, Finance & CAO | Sell | 2,500 | $58.59 | $146.5K | 30,867 |
| Mar 11, 2026↗ | Wassil Jim | officer: CHIEF OPERATING OFFICER | Sell | 7,395 | $58.88 | $435.4K | 171,786 |
| Sep 8, 2025↗ | Dhaliwal Harpreet S. | Chief Technical Ops Officer | Sell | 1,204 | $32.41 | $39.0K | 0 |
| Sep 2, 2025↗ | Dhaliwal Harpreet S. | Chief Technical Ops Officer | Sell | 1,538 | $31.56 | $48.5K | 0 |
| Sep 2, 2025↗ | GUGGENHIME ANDREW | PRESIDENT AND CFO | Sell | 5,080 | $31.56 | $160.3K | 0 |
| Feb 27, 2025↗ | PICKERING GRANT | CHIEF EXECUTIVE OFFICER | Sell | 9,997 | $72.29 | $722.6K | 0 |
| Feb 27, 2025↗ | Wassil Jim | CHIEF OPERATING OFFICER | Sell | 15,154 | $72.97 | $1.11M | 0 |
| Feb 19, 2025↗ | GUGGENHIME ANDREW | PRESIDENT AND CFO | Sell | 8,000 | $83.85 | $670.8K | 111,309 |
| Feb 7, 2025↗ | Eydelman Mikhail | SVP, GEN COUNSEL & CORP SEC | Sell | 5,000 | $90.07 | $450.4K | 32,651 |
| Feb 4, 2025↗ | Wassil Jim | CHIEF OPERATING OFFICER | Sell | 8,000 | $86.22 | $689.8K | 208,381 |
| Jan 22, 2025↗ | GUGGENHIME ANDREW | PRESIDENT AND CFO | Sell | 8,000 | $86.51 | $692.1K | 112,173 |
| Jan 17, 2025↗ | Loxam Teri | Director | Sell | 6,250 | $85.11 | $532.0K | 13,279 |
| Jan 7, 2025↗ | Eydelman Mikhail | SVP, GEN COUNSEL & CORP SEC | Sell | 5,000 | $85.58 | $427.9K | 32,268 |
| Jan 3, 2025↗ | Wassil Jim | CHIEF OPERATING OFFICER | Sell | 8,000 | $83.66 | $669.3K | 212,339 |
| Dec 19, 2024↗ | GUGGENHIME ANDREW | PRESIDENT AND CFO | Sell | 8,000 | $88.78 | $710.2K | 116,301 |
| Dec 10, 2024↗ | PICKERING GRANT | CHIEF EXECUTIVE OFFICER | Sell | 2,366 | $92.25 | $218.3K | 136,437 |
| Dec 9, 2024↗ | Eydelman Mikhail | SVP, GEN COUNSEL & CORP SEC | Sell | 5,000 | $91.49 | $457.4K | 32,262 |
| Dec 3, 2024↗ | PICKERING GRANT | CHIEF EXECUTIVE OFFICER | Sell | 15,000 | $92.45 | $1.39M | 453,952 |
| Dec 3, 2024↗ | Wassil Jim | CHIEF OPERATING OFFICER | Sell | 8,000 | $92.49 | $739.9K | 207,923 |
| Nov 19, 2024↗ | GUGGENHIME ANDREW | PRESIDENT AND CFO | Sell | 8,000 | $85.81 | $686.5K | 111,380 |
| Nov 8, 2024↗ | PICKERING GRANT | CHIEF EXECUTIVE OFFICER | Sell | 2,366 | $103.89 | $245.8K | 138,354 |
| Nov 6, 2024↗ | Eydelman Mikhail | SVP, GEN COUNSEL & CORP SEC | Sell | 5,000 | $106.36 | $531.8K | 32,835 |
| Nov 4, 2024↗ | PICKERING GRANT | CHIEF EXECUTIVE OFFICER | Sell | 15,000 | $106.82 | $1.60M | 440,264 |
| Nov 4, 2024↗ | Wassil Jim | CHIEF OPERATING OFFICER | Sell | 8,000 | $106.80 | $854.4K | 208,740 |
| Oct 22, 2024↗ | GUGGENHIME ANDREW | PRESIDENT AND CFO | Sell | 42,000 | $115.39 | $4.85M | 96,269 |
| Oct 8, 2024↗ | Eydelman Mikhail | SVP, GEN COUNSEL & CORP SEC | Sell | 5,000 | $109.27 | $546.4K | 33,147 |
| Oct 8, 2024↗ | PICKERING GRANT | CHIEF EXECUTIVE OFFICER | Sell | 7,098 | $109.21 | $775.2K | 141,820 |
| Oct 3, 2024↗ | Eydelman Mikhail | SVP, GEN COUNSEL & CORP SEC | Sell | 5,500 | $114.24 | $628.3K | 32,709 |
| Oct 3, 2024↗ | PICKERING GRANT | CHIEF EXECUTIVE OFFICER | Sell | 55,000 | $114.25 | $6.28M | 465,914 |
| Oct 3, 2024↗ | Wassil Jim | CHIEF OPERATING OFFICER | Sell | 8,000 | $114.24 | $913.9K | 206,334 |
| Sep 19, 2024↗ | GUGGENHIME ANDREW | PRESIDENT AND CFO | Sell | 8,000 | $115.94 | $927.5K | 92,898 |
| Sep 18, 2024↗ | Loxam Teri | Director | Sell | 6,250 | $116.28 | $726.7K | 13,184 |
| Sep 18, 2024↗ | Wassil Jim | CHIEF OPERATING OFFICER | Sell | 10,000 | $115.96 | $1.16M | 210,174 |
| Sep 5, 2024↗ | Cowan Elvia | SVP, FINANCE | Sell | 5,000 | $107.67 | $538.4K | 12,723 |
| Sep 5, 2024↗ | Eydelman Mikhail | SVP, GEN COUNSEL & CORP SEC | Sell | 1,667 | $112.11 | $186.9K | 32,489 |
| Sep 5, 2024↗ | Wassil Jim | CHIEF OPERATING OFFICER | Sell | 10,000 | $111.93 | $1.12M | 217,245 |
| Aug 26, 2024↗ | PICKERING GRANT | CHIEF EXECUTIVE OFFICER | Sell | 15,000 | $78.98 | $1.18M | 487,202 |
| Aug 20, 2024↗ | GUGGENHIME ANDREW | PRESIDENT AND CFO | Sell | 8,000 | $78.58 | $628.6K | 99,726 |
| Aug 5, 2024↗ | Eydelman Mikhail | SVP, GEN COUNSEL & CORP SEC | Sell | 1,667 | $78.85 | $131.4K | 31,011 |
| Aug 5, 2024↗ | PICKERING GRANT | CHIEF EXECUTIVE OFFICER | Sell | 2,616 | $78.79 | $206.1K | 142,130 |
| Aug 5, 2024↗ | Wassil Jim | CHIEF OPERATING OFFICER | Sell | 3,000 | $78.84 | $236.5K | 207,526 |
| Jul 24, 2024↗ | PICKERING GRANT | CHIEF EXECUTIVE OFFICER | Sell | 15,000 | $84.26 | $1.26M | 488,170 |
| Jul 22, 2024↗ | GUGGENHIME ANDREW | PRESIDENT AND CFO | Sell | 8,000 | $81.17 | $649.3K | 101,625 |
| Jul 17, 2024↗ | Cowan Elvia | SVP, FINANCE | Sell | 5,000 | $85.00 | $425.0K | 12,723 |
| Jul 9, 2024↗ | Cowan Elvia | SVP, FINANCE | Sell | 5,000 | $80.00 | $400.0K | 12,723 |
| Jul 2, 2024↗ | Eydelman Mikhail | SVP, GEN COUNSEL & CORP SEC | Sell | 1,667 | $76.37 | $127.3K | 31,580 |
| Jul 2, 2024↗ | PICKERING GRANT | CHIEF EXECUTIVE OFFICER | Sell | 2,616 | $76.33 | $199.7K | 144,072 |
| Jul 2, 2024↗ | Wassil Jim | CHIEF OPERATING OFFICER | Sell | 3,000 | $76.34 | $229.0K | 212,277 |
| Jun 25, 2024↗ | PICKERING GRANT | CHIEF EXECUTIVE OFFICER | Sell | 15,000 | $75.64 | $1.13M | 483,547 |
| Jun 20, 2024↗ | GUGGENHIME ANDREW | PRESIDENT AND CFO | Sell | 8,000 | $71.92 | $575.4K | 97,068 |
Showing 1–50 of 176
1 / 4
PCVX Insider Buying Activity
The following table shows recent insider purchases of Vaxcyte, Inc. (PCVX) stock reported via SEC Form 4 filings.
No insider buying activity found for PCVX in the last 12 months.
PCVX Insider Selling Activity
The following table shows recent insider sales of Vaxcyte, Inc. (PCVX) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Mar 11, 2026↗ | Cowan Elvia | officer: SVP, Finance & CAO | Sell | 2,500 | $58.59 | $146.5K | 30,867 |
| Mar 11, 2026↗ | Wassil Jim | officer: CHIEF OPERATING OFFICER | Sell | 7,395 | $58.88 | $435.4K | 171,786 |
| Sep 8, 2025↗ | Dhaliwal Harpreet S. | Chief Technical Ops Officer | Sell | 1,204 | $32.41 | $39.0K | 0 |
| Sep 2, 2025↗ | Dhaliwal Harpreet S. | Chief Technical Ops Officer | Sell | 1,538 | $31.56 | $48.5K | 0 |
| Sep 2, 2025↗ | GUGGENHIME ANDREW | PRESIDENT AND CFO | Sell | 5,080 | $31.56 | $160.3K | 0 |
| Feb 27, 2025↗ | PICKERING GRANT | CHIEF EXECUTIVE OFFICER | Sell | 9,997 | $72.29 | $722.6K | 0 |
| Feb 27, 2025↗ | Wassil Jim | CHIEF OPERATING OFFICER | Sell | 15,154 | $72.97 | $1.11M | 0 |
| Feb 19, 2025↗ | GUGGENHIME ANDREW | PRESIDENT AND CFO | Sell | 8,000 | $83.85 | $670.8K | 111,309 |
| Feb 7, 2025↗ | Eydelman Mikhail | SVP, GEN COUNSEL & CORP SEC | Sell | 5,000 | $90.07 | $450.4K | 32,651 |
| Feb 4, 2025↗ | Wassil Jim | CHIEF OPERATING OFFICER | Sell | 8,000 | $86.22 | $689.8K | 208,381 |
| Jan 22, 2025↗ | GUGGENHIME ANDREW | PRESIDENT AND CFO | Sell | 8,000 | $86.51 | $692.1K | 112,173 |
| Jan 17, 2025↗ | Loxam Teri | Director | Sell | 6,250 | $85.11 | $532.0K | 13,279 |
| Jan 7, 2025↗ | Eydelman Mikhail | SVP, GEN COUNSEL & CORP SEC | Sell | 5,000 | $85.58 | $427.9K | 32,268 |
| Jan 3, 2025↗ | Wassil Jim | CHIEF OPERATING OFFICER | Sell | 8,000 | $83.66 | $669.3K | 212,339 |
| Dec 19, 2024↗ | GUGGENHIME ANDREW | PRESIDENT AND CFO | Sell | 8,000 | $88.78 | $710.2K | 116,301 |
| Dec 10, 2024↗ | PICKERING GRANT | CHIEF EXECUTIVE OFFICER | Sell | 2,366 | $92.25 | $218.3K | 136,437 |
| Dec 9, 2024↗ | Eydelman Mikhail | SVP, GEN COUNSEL & CORP SEC | Sell | 5,000 | $91.49 | $457.4K | 32,262 |
| Dec 3, 2024↗ | PICKERING GRANT | CHIEF EXECUTIVE OFFICER | Sell | 15,000 | $92.45 | $1.39M | 453,952 |
| Dec 3, 2024↗ | Wassil Jim | CHIEF OPERATING OFFICER | Sell | 8,000 | $92.49 | $739.9K | 207,923 |
| Nov 19, 2024↗ | GUGGENHIME ANDREW | PRESIDENT AND CFO | Sell | 8,000 | $85.81 | $686.5K | 111,380 |
| Nov 8, 2024↗ | PICKERING GRANT | CHIEF EXECUTIVE OFFICER | Sell | 2,366 | $103.89 | $245.8K | 138,354 |
| Nov 6, 2024↗ | Eydelman Mikhail | SVP, GEN COUNSEL & CORP SEC | Sell | 5,000 | $106.36 | $531.8K | 32,835 |
| Nov 4, 2024↗ | PICKERING GRANT | CHIEF EXECUTIVE OFFICER | Sell | 15,000 | $106.82 | $1.60M | 440,264 |
| Nov 4, 2024↗ | Wassil Jim | CHIEF OPERATING OFFICER | Sell | 8,000 | $106.80 | $854.4K | 208,740 |
| Oct 22, 2024↗ | GUGGENHIME ANDREW | PRESIDENT AND CFO | Sell | 42,000 | $115.39 | $4.85M | 96,269 |
| Oct 8, 2024↗ | Eydelman Mikhail | SVP, GEN COUNSEL & CORP SEC | Sell | 5,000 | $109.27 | $546.4K | 33,147 |
| Oct 8, 2024↗ | PICKERING GRANT | CHIEF EXECUTIVE OFFICER | Sell | 7,098 | $109.21 | $775.2K | 141,820 |
| Oct 3, 2024↗ | Eydelman Mikhail | SVP, GEN COUNSEL & CORP SEC | Sell | 5,500 | $114.24 | $628.3K | 32,709 |
| Oct 3, 2024↗ | PICKERING GRANT | CHIEF EXECUTIVE OFFICER | Sell | 55,000 | $114.25 | $6.28M | 465,914 |
| Oct 3, 2024↗ | Wassil Jim | CHIEF OPERATING OFFICER | Sell | 8,000 | $114.24 | $913.9K | 206,334 |
| Sep 19, 2024↗ | GUGGENHIME ANDREW | PRESIDENT AND CFO | Sell | 8,000 | $115.94 | $927.5K | 92,898 |
| Sep 18, 2024↗ | Loxam Teri | Director | Sell | 6,250 | $116.28 | $726.7K | 13,184 |
| Sep 18, 2024↗ | Wassil Jim | CHIEF OPERATING OFFICER | Sell | 10,000 | $115.96 | $1.16M | 210,174 |
| Sep 5, 2024↗ | Cowan Elvia | SVP, FINANCE | Sell | 5,000 | $107.67 | $538.4K | 12,723 |
| Sep 5, 2024↗ | Eydelman Mikhail | SVP, GEN COUNSEL & CORP SEC | Sell | 1,667 | $112.11 | $186.9K | 32,489 |
| Sep 5, 2024↗ | Wassil Jim | CHIEF OPERATING OFFICER | Sell | 10,000 | $111.93 | $1.12M | 217,245 |
| Aug 26, 2024↗ | PICKERING GRANT | CHIEF EXECUTIVE OFFICER | Sell | 15,000 | $78.98 | $1.18M | 487,202 |
| Aug 20, 2024↗ | GUGGENHIME ANDREW | PRESIDENT AND CFO | Sell | 8,000 | $78.58 | $628.6K | 99,726 |
| Aug 5, 2024↗ | Eydelman Mikhail | SVP, GEN COUNSEL & CORP SEC | Sell | 1,667 | $78.85 | $131.4K | 31,011 |
| Aug 5, 2024↗ | PICKERING GRANT | CHIEF EXECUTIVE OFFICER | Sell | 2,616 | $78.79 | $206.1K | 142,130 |
| Aug 5, 2024↗ | Wassil Jim | CHIEF OPERATING OFFICER | Sell | 3,000 | $78.84 | $236.5K | 207,526 |
| Jul 24, 2024↗ | PICKERING GRANT | CHIEF EXECUTIVE OFFICER | Sell | 15,000 | $84.26 | $1.26M | 488,170 |
| Jul 22, 2024↗ | GUGGENHIME ANDREW | PRESIDENT AND CFO | Sell | 8,000 | $81.17 | $649.3K | 101,625 |
| Jul 17, 2024↗ | Cowan Elvia | SVP, FINANCE | Sell | 5,000 | $85.00 | $425.0K | 12,723 |
| Jul 9, 2024↗ | Cowan Elvia | SVP, FINANCE | Sell | 5,000 | $80.00 | $400.0K | 12,723 |
| Jul 2, 2024↗ | Eydelman Mikhail | SVP, GEN COUNSEL & CORP SEC | Sell | 1,667 | $76.37 | $127.3K | 31,580 |
| Jul 2, 2024↗ | PICKERING GRANT | CHIEF EXECUTIVE OFFICER | Sell | 2,616 | $76.33 | $199.7K | 144,072 |
| Jul 2, 2024↗ | Wassil Jim | CHIEF OPERATING OFFICER | Sell | 3,000 | $76.34 | $229.0K | 212,277 |
| Jun 25, 2024↗ | PICKERING GRANT | CHIEF EXECUTIVE OFFICER | Sell | 15,000 | $75.64 | $1.13M | 483,547 |
| Jun 20, 2024↗ | GUGGENHIME ANDREW | PRESIDENT AND CFO | Sell | 8,000 | $71.92 | $575.4K | 97,068 |
PCVX Insiders
Similar Stocks to PCVX
VRTX
Vertex Pharmaceuticals Incorporated
$470.20-1.66%
$121.44B
REGN
Regeneron Pharmaceuticals, Inc.
$743.51-0.41%
$77.57B
ALNY
Alnylam Pharmaceuticals, Inc.
$313.45-1.19%
$42.07B
INSM
Insmed Incorporated
$139.06-0.33%
$30.07B
UTHR
United Therapeutics Corporation
$536.12+0.97%
$23.50B
MRNA
Moderna, Inc.
$52.56-1.89%
$20.76B
ROIV
Roivant Sciences Ltd.
$28.06-1.44%
$20.08B
RPRX
Royalty Pharma plc
$45.65-0.57%
$19.56B